Details for New Drug Application (NDA): 060613
✉ Email this page to a colleague
The generic ingredient in CASPORYN HC is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 060613
Tradename: | CASPORYN HC |
Applicant: | Casper Pharma Llc |
Ingredient: | hydrocortisone; neomycin sulfate; polymyxin b sulfate |
Patents: | 0 |
Pharmacology for NDA: 060613
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 060613
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CASPORYN HC | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OTIC | 060613 | NDA AUTHORIZED GENERIC | A-S Medication Solutions | 50090-6336 | 50090-6336-0 | 1 BOTTLE in 1 CARTON (50090-6336-0) / 10 mL in 1 BOTTLE |
CASPORYN HC | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OTIC | 060613 | NDA AUTHORIZED GENERIC | Rising Pharma Holdings, Inc. | 64980-448 | 64980-448-01 | 1 BOTTLE in 1 CARTON (64980-448-01) / 10 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OTIC | Strength | 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | Yes |
Complete Access Available with Subscription